Literature DB >> 24055448

Neurological approaches for investigating West Nile virus disease and its treatment in rodents.

John D Morrey1, Venkatraman Siddharthan, Hong Wang.   

Abstract

West Nile virus (WNV) has had a major public health impact since its emergence in the Western Hemisphere; in 2012, nearly 3000 cases of WN neuroinvasive disease were identified in the United States. The underlying mechanisms of WN neurologic disease can only be studied to a limited extent in patients, but can be investigated in much greater detail in animal models. In this paper, we describe how we and others have employed a variety of electrophysiological and neurological techniques to study experimental WNV infections in hamsters and mice. The methods have included electrophysiological motor unit number estimation; optogenetic photoactivation of the spinal cord and electromyography; plethysmography; measurement of heart rate variability as an indication of autonomic nervous system dysfunction; and an assessment of spatial memory loss using the Morris water maze. These techniques provide a more refined assessment of disease manifestations in rodents than traditional measurements of weight loss and mortality, and should make it possible to identify targets for therapeutic intervention and to directly assess the effects of novel treatments.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic; Electromyography; Optogenetic; Plethysmography; Spinal cord; West Nile virus

Mesh:

Year:  2013        PMID: 24055448      PMCID: PMC5705084          DOI: 10.1016/j.antiviral.2013.09.010

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  93 in total

1.  Recovery and prognosticators of paralysis in West Nile virus infection.

Authors:  Nancy Jingyang Cao; Chakpapani Ranganathan; William J Kupsky; Jun Li
Journal:  J Neurol Sci       Date:  2005-09-15       Impact factor: 3.181

2.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

3.  West Nile virus blood transfusion-related infection despite nucleic acid testing.

Authors:  Alexandre Macedo de Oliveira; Brady D Beecham; Susan P Montgomery; Robert S Lanciotti; Jeffrey M Linnen; Cristina Giachetti; Larry A Pietrelli; Susan L Stramer; Thomas J Safranek
Journal:  Transfusion       Date:  2004-12       Impact factor: 3.157

4.  Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.

Authors:  John D Morrey; Venkatraman Siddharthan; Aaron L Olsen; Hong Wang; Justin G Julander; Jeffery O Hall; Hua Li; Jeffrey L Nordstrom; Scott Koenig; Syd Johnson; Michael S Diamond
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

5.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Neurocognitive and functional outcomes in persons recovering from West Nile virus illness.

Authors:  James J Sejvar; Aaron T Curns; Leonie Welburg; James F Jones; Louisa M Lundgren; Lucile Capuron; John Pape; William C Reeves; Grant L Campbel
Journal:  J Neuropsychol       Date:  2008-09       Impact factor: 2.864

Review 7.  The long-term outcomes of human West Nile virus infection.

Authors:  James J Sejvar
Journal:  Clin Infect Dis       Date:  2007-05-02       Impact factor: 9.079

8.  Virus and antibody dynamics in acute west nile virus infection.

Authors:  Michael P Busch; Steven H Kleinman; Leslie H Tobler; Hany T Kamel; Philip J Norris; Irina Walsh; Jose L Matud; Harry E Prince; Robert S Lanciotti; David J Wright; Jeffrey M Linnen; Sally Caglioti
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

9.  Urinary retention in a patient with West Nile virus.

Authors:  Andrew I Shpall; Arousiak Varpetian; David A Ginsberg
Journal:  Urology       Date:  2003-06       Impact factor: 2.649

10.  Autonomic deficit not the cause of death in West Nile virus neurological disease.

Authors:  Hong Wang; Venkatraman Siddharthan; Jeffery O Hall; John D Morrey
Journal:  Clin Auton Res       Date:  2013-10-25       Impact factor: 4.435

View more
  3 in total

1.  A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.

Authors:  Neal Van Hoeven; Sharvari Waghmare Joshi; Ghislain Ismael Nana; Angela Bosco-Lauth; Christopher Fox; Richard A Bowen; David E Clements; Timothy Martyak; D Elliot Parks; Susan Baldwin; Steven G Reed; Rhea N Coler
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

2.  Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters.

Authors:  Katherine Zukor; Hong Wang; Brett L Hurst; Venkatraman Siddharthan; Arnaud Van Wettere; Paul M Pilowsky; John D Morrey
Journal:  J Neurovirol       Date:  2016-10-19       Impact factor: 2.643

3.  Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.

Authors:  Brian E Dawes; Junling Gao; Colm Atkins; Jacob T Nelson; Kendra Johnson; Ping Wu; Alexander N Freiberg
Journal:  J Neuroinflammation       Date:  2018-11-15       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.